You are here » Home » Companies » Company Overview » Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Ltd.

BSE: 524500 Sector: Health care
NSE: KILITCH ISIN Code: INE729D01010
BSE LIVE 15:57 | 15 Dec 90.90 2.35
(2.65%)
OPEN

91.45

HIGH

92.00

LOW

89.05

NSE 15:31 | 15 Dec 89.75 1.15
(1.30%)
OPEN

91.00

HIGH

92.00

LOW

87.15

OPEN 91.45
PREVIOUS CLOSE 88.55
VOLUME 4805
52-Week high 92.95
52-Week low 34.70
P/E 69.39
Mkt Cap.(Rs cr) 120
Buy Price 0.00
Buy Qty 0.00
Sell Price 90.45
Sell Qty 12.00
OPEN 91.45
CLOSE 88.55
VOLUME 4805
52-Week high 92.95
52-Week low 34.70
P/E 69.39
Mkt Cap.(Rs cr) 120
Buy Price 0.00
Buy Qty 0.00
Sell Price 90.45
Sell Qty 12.00

Kilitch Drugs (India) Ltd. (KILITCH) - Chairman Speech

Company chairman speech

Dear Valued Shareholders

On behalf of the Board of Directors

I extend a warm Welcome to all of you to the 24th Annual General Meeting of ourcompany.

During the course of the year exports touched the highest levels with businessactivities being opened up in new markets across the globe.

During the year 2015-16 we initiated a number of strategically guided and decisivesteps which shall help us in establishing as market leader in years to come.

With the addition of more products in effervescence range the company has now become amarket leader in the said range in the Francophone Countries.

New Marketing techniques coupled with promotional campaigns have made way for ourproducts in those markets.

I believe that we have opened up various new horizons across all our lines of business.

I intend to reassure our commitment to the stakeholders and we shall always thrive forthe same.

Mukund P. Mehta

Managing Director